LeonaBio (LONA) Other Working Capital Changes (2020 - 2026)
LeonaBio's (LONA) quarterly Other Working Capital Changes came in at -$183000.0 in Q1 2026, down 83.0% year-on-year from -$1.1 million in Q1 2025, and down 174.39% on a QoQ basis from $246000.0 in Q4 2025.
LeonaBio (LONA) Other Working Capital Changes (2020 - 2026) Analysis & Trends
LeonaBio (LONA) has 7 years of Other Working Capital Changes data on file, last reported at -$183000.0 in Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 83.0% year-over-year to -$183000.0 in Q1 2026; TTM through Mar 2026 was -$142000.0, a 62.73% increase from a year earlier, with the FY2025 full-year figure at -$59000.0, up 83.97% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$183000.0, down from $246000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for LONA reached as high as $2.8 million in Q3 2022 and fell as low as -$1.8 million in Q3 2024.
- Historically, Other Working Capital Changes has averaged -$187176.5 across 5 years, with a median of -$348000.0 in 2022.
- On a YoY basis, Other Working Capital Changes climbed as much as 394.03% in 2022 and fell as far as 311.76% in 2022.
- Year by year, Other Working Capital Changes stood at $197000.0 in 2022, then plunged by 144.16% to -$87000.0 in 2023, then fell by 11.49% to -$97000.0 in 2024, then soared by 353.61% to $246000.0 in 2025, then slumped by 174.39% to -$183000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$183000.0 in Q1 2026, $246000.0 in Q4 2025, and -$105000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | LeonaBio | 138.33 Mn | 70.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 396,000.00 |
| Mar 31, 2026 | 396,000.00 |
| Mar 31, 2026 | 396,000.00 |
| Dec 31, 2025 | -672,000.00 |
| Dec 31, 2025 | -672,000.00 |
| Dec 31, 2025 | -672,000.00 |
| Sep 30, 2025 | -603,000.00 |
| Sep 30, 2025 | -603,000.00 |
| Sep 30, 2025 | -603,000.00 |
| Jun 30, 2025 | -811,000.00 |
| Jun 30, 2025 | -811,000.00 |
| Jun 30, 2025 | -811,000.00 |
| Mar 31, 2025 | -353,000.00 |
| Mar 31, 2025 | -353,000.00 |
| Mar 31, 2025 | -353,000.00 |
| Dec 31, 2024 | 421,000.00 |
| Dec 31, 2024 | 421,000.00 |
| Dec 31, 2024 | 421,000.00 |
| Sep 30, 2024 | -1.79 Mn |
| Sep 30, 2024 | -1.79 Mn |